Pharmacokinetic and Biopharmaceutical Considerations in Prodrug Discovery and Development
作者
John P. O’Donnell
出处
期刊:Methods and principles in medicinal chemistry [Wiley] 日期:2010-12-15卷期号:: 415-452被引量:1
标识
DOI:10.1002/9783527633166.ch15
摘要
This chapter contains sections titled: Introduction Understanding Pharmacokinetic/Pharmacodynamic Relationships Pharmacokinetics Tools for the Prodrug Scientist Enzymes Involved with Prodrug Conversion Use of the Caco-2 System for Permeability and Active Transport Evaluation XP13512: Improving PK Performance by Targeting Active Transport Prodrug Absorption: Transport/Metabolic Conversion Interplay Preabsorptive Degradation Biopharmaceutical-Based PK Modeling for Prodrug Design Conclusions References